|  Help  |  About  |  Contact Us

Publication : A novel mitochondrial carnitine-acylcarnitine translocase induced by partial hepatectomy and fasting.

First Author  Sekoguchi E Year  2003
Journal  J Biol Chem Volume  278
Issue  40 Pages  38796-802
PubMed ID  12882971 Mgi Jnum  J:85838
Mgi Id  MGI:2677114 Doi  10.1074/jbc.M306372200
Citation  Sekoguchi E, et al. (2003) A novel mitochondrial carnitine-acylcarnitine translocase induced by partial hepatectomy and fasting. J Biol Chem 278(40):38796-802
abstractText  The carnitine-dependent transport of long-chain fatty acids is essential for fatty acid catabolism. In this system, the fatty acid moiety of acyl-CoA is transferred enzymatically to carnitine, and the resultant product, acylcarnitine, is imported into the mitochondrial matrix through a transporter named carnitine-acylcarnitine translocase (CACT). Here we report a novel mammalian protein homologous to CACT. The protein, designated as CACL (CACT-like), is localized to the mitochondria and has palmitoylcarnitine transporting activity. The tissue distribution of CACL is similar to that of CACT; both are expressed at a higher level in tissues using fatty acids as fuels, except in the brain, where only CACL is expressed. In addition, CACL is induced by partial hepatectomy or fasting. Thus, CACL may play an important role cooperatively with its homologue CACT in a stress-induced change of lipid metabolism, and may be specialized for the metabolism of a distinct class of fatty acids involved in brain function.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Bio Entities

Trail: Publication

0 Expression